Late infective endocarditis after transcatheter tricuspid valve-in-valve implantation: A pediatric case report.


Journal

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
ISSN: 1769-664X
Titre abrégé: Arch Pediatr
Pays: France
ID NLM: 9421356

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 17 07 2019
revised: 04 10 2019
accepted: 30 12 2019
pubmed: 21 1 2020
medline: 25 11 2020
entrez: 21 1 2020
Statut: ppublish

Résumé

In patients with congenital heart diseases, new procedures, such as transcatheter valve replacement, have been associated with a non-negligible incidence of infective endocarditis (IE): up to 4% patient-year IE incidence. Prosthetic IE after percutaneous tricuspid valve replacement (PTVR) has been scarcely reported. We report the first pediatric case of IE after percutaneous tricuspid Melody™ valve-in-valve implantation in a boy who was diagnosed with Eisenmenger syndrome, related to patent ductus arteriosus. This first pediatric case of late IE (4 years) after PTVR is added to eight previously reported cases of IE from the valve-in-valve international database registry (VIVID registry).

Identifiants

pubmed: 31955957
pii: S0929-693X(19)30227-1
doi: 10.1016/j.arcped.2019.12.002
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107-109

Informations de copyright

Copyright © 2020 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

A Gavotto (A)

Department of Pediatric and Congenital Cardiology, M3C Regional Reference Center, Montpellier University Hospital, PhyMedExp, Inserm, CNRS, University of Montpellier, 34295 Montpellier, France. Electronic address: a-gavotto@chu-montpellier.fr.

O Werner (O)

Pediatric and Congenital Cardiology Department, M3C Regional Center, University Hospital, 34295 Montpellier, France.

P Amedro (P)

Department of Pediatric and Congenital Cardiology, M3C Regional Reference Center, Montpellier University Hospital, PhyMedExp, Inserm, CNRS, University of Montpellier, 34295 Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH